KAYS (Kaya Holdings) Cyclically Adjusted PB Ratio: (As of Jul. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Kaya Holdings Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Kaya Holdings  (OTCPK:KAYS) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Kaya Holdings Cyclically Adjusted PB Ratio Related Terms


Kaya Holdings Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Kaya Holdings's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kaya Holdings Cyclically Adjusted PB Ratio Chart

Kaya Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Kaya Holdings Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

KAYS vs APUS, IGPK, BIOE: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kaya Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kaya Holdings Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kaya Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Kaya Holdings's Cyclically Adjusted PB Ratio falls into.



Kaya Holdings Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Kaya Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2025 is calculated as:

For example, Kaya Holdings's adjusted Book Value per Share data for the three months ended in Sep. 2025 was:

Adj_Book=Book Value per Share/CPI of Sep. 2025 (Change)*Current CPI (Sep. 2025)
=-0.001/324.8000*324.8000
=-0.001

Current CPI (Sep. 2025) = 324.8000.

Kaya Holdings Quarterly Data

Book Value per Share CPI Adj_Book
201512 -0.791 236.525 -1.086
201603 -0.573 238.132 -0.782
201606 -0.603 241.018 -0.813
201609 -0.633 241.428 -0.852
201612 -2.609 241.432 -3.510
201703 -2.219 243.801 -2.956
201706 -1.506 244.955 -1.997
201709 -1.863 246.819 -2.452
201712 -3.407 246.524 -4.489
201803 -2.027 249.554 -2.638
201806 -2.178 251.989 -2.807
201809 -1.299 252.439 -1.671
201812 -2.014 251.233 -2.604
201903 -1.553 254.202 -1.984
201906 -1.217 256.143 -1.543
201909 -1.146 256.759 -1.450
201912 -0.973 256.974 -1.230
202003 -1.024 258.115 -1.289
202006 -1.138 257.797 -1.434
202009 -1.887 260.280 -2.355
202012 -1.641 260.474 -2.046
202103 -2.002 264.877 -2.455
202106 -1.220 271.696 -1.458
202109 -1.034 274.310 -1.224
202112 -0.855 278.802 -0.996
202203 -0.928 287.504 -1.048
202206 -0.717 296.311 -0.786
202209 -1.220 296.808 -1.335
202212 -0.704 296.797 -0.770
202303 -0.695 301.836 -0.748
202306 -0.727 305.109 -0.774
202309 -0.634 307.789 -0.669
202312 -0.622 306.746 -0.659
202403 -0.671 312.332 -0.698
202406 -0.652 314.175 -0.674
202409 -0.387 315.301 -0.399
202412 -0.362 315.605 -0.373
202503 -0.401 319.799 -0.407
202506 -0.460 322.561 -0.463
202509 -0.001 324.800 -0.001

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Kaya Holdings Business Description

Address 21218 St. Andrews Boulevard, Suite 300, Boca Raton, FL, USA, 33433
Kaya Holdings Inc is a holding company. It is focusing on wellness and mental health through operations in psychedelic treatment clinics, medical and recreational cannabis, and CBD products. The company own and operate a medical cannabis dispensary in the United States. Its has produced, distributed, and/or sold a full range of premium cannabis products including flower, oils, vape cartridges and cannabis infused confections, baked goods and beverages through a fully integrated group of subsidiaries and companies supporting distinctive brands.